Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
A new approach to study the distribution of fibrin(ogen)-related antigens was investigated using three different monoclonal antibodies (MAbs) and the avidin-biotin complex immunoperoxidase technique. MAb I8C6 recognizes B beta 1-42 peptide and can react with either fibrinogen or fibrin I; MAb T2G1 recognizes B beta 15-42 peptide and detects fibrin II but does not cross-react with fibrinogen; MAb GC4 reacts with Fragments D/DD derived from plasmin degradation of fibrinogen or fibrin but not with intact fibrinogen. The method can be applied to frozen or Bouin's fixed paraffin-embedded tissues obtained at biopsy, surgery, and autopsy. The distribution of the three antigens observed with the three MAbs was compared with that obtained with a polyclonal antiserum to fibrinogen and with the more conventional histochemical stains used in pathology to demonstrate fibrin deposits in tissues (Lendrum and PTAH). The staining observed with the three monoclonals clearly detected three different populations of fibrin(ogen)-related antigen in the tissues examined. The staining with MAb T2G1 specifically detected fibrin II with greater sensitivity than did conventional stains. The results of this study suggest that this method allows the molecular form of fibrin(ogen)-related deposits in tissues to be determined and this information may help to elucidate the role of fibrin in various disease states, such as atherosclerosis and renal disease, and in tumor growth and metastasis.
Bini
A
A
Department of Medicine, Columbia University, New York 10032.
Mesa-Tejada
R
R
Fenoglio
J J
JJ
Kudryk
B
B
Kaplan
K L
KL
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D000941:Antigens / Q000032:analysis*; D001853:Bone Marrow / Q000032:analysis; D003331:Coronary Vessels / Q000032:analysis; D003429:Cross Reactions; D005260:Female; D005263:Femoral Artery / Q000032:analysis; D005337:Fibrin / Q000032:analysis* / Q000276:immunology; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis / Q000276:immunology; D005340:Fibrinogen / Q000032:analysis* / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007124:Immunoenzyme Techniques; D007678:Kidney Glomerulus / Q000032:analysis; D008168:Lung / Q000032:analysis; D010920:Placenta / Q000032:analysis; D011247:Pregnancy
D000911:Antibodies, Monoclonal; D000941:Antigens; D005338:Fibrin Fibrinogen Degradation Products; D007106:Immune Sera; D005337:Fibrin; D005340:Fibrinogen